Brain-Liver Connection Reveals How Stress Elevates Blood Sugar and Risks for Type 2 Diabetes

A groundbreaking study uncovers a neural pathway from the amygdala to the liver that links stress to increased blood sugar levels, providing new insights into diabetes risk and potential treatment targets.
Recent research has uncovered a critical neural circuit in the brain that links stress responses to glucose regulation, shedding light on how chronic stress can contribute to the development of type 2 diabetes. The study, published in Nature, identified a pathway from the amygdala—a region involved in emotional processing—to the liver that regulates blood glucose levels. Under normal conditions, in stressful situations, this circuit prompts a burst of energy by increasing glucose production in the liver. However, the findings reveal that prolonged stress or a high-fat diet alters this pathway, causing persistent overproduction of glucose, which can lead to hyperglycemia and long-term risk of diabetes.
This research is groundbreaking as it is the first to describe how the medial amygdala influences liver glucose output. Previously, control of blood glucose was mainly associated with the hypothalamus and brainstem, regions responsible for homeostatic functions like hunger and thirst. The discovery that the amygdala, which processes emotional responses, also drives glucose production underscores the significant impact of stress on metabolic health.
In experiments using mice, scientists observed that various stressors, such as social or visual stress, increased activity in the medial amygdala, coinciding with a rise in blood glucose levels by up to 70%. When this region was artificially activated, glucose levels increased even without actual stress, confirming its role in glucose regulation. Neuronal tracing demonstrated that activation of the amygdala stimulates pathways through the hypothalamus to the liver, leading to increased glucose release.
The study further revealed that repeated stress combined with a fatty diet alters this neural circuit, causing a state of desensitization. This results in sustained elevated glucose levels, elevating the risk for diabetes. Importantly, these findings suggest that targeting this brain-liver pathway could offer new strategies for preventing and managing metabolic disorders, especially in individuals exposed to chronic stress.
This research shifts our understanding of stress from merely affecting behavior to directly influencing physiological processes involved in energy regulation. It highlights the importance of managing stress not only for mental health but also for preventing metabolic diseases like diabetes. Further research is needed to explore how short-term and long-term stress modify this neural circuit at the cellular and molecular levels, and whether stress reduction interventions can reverse circuit disruptions and reduce disease risk.
By uncovering how emotional and neural pathways influence body metabolism, this study opens new avenues for treatments aimed at improving glucose control and reducing the burden of type 2 diabetes worldwide. It also emphasizes the broader health implications of social determinants of health, proposing that reducing societal stressors could have a profound impact on metabolic health outcomes, including diabetes prevention.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Living on a Farm During Childhood May Reduce Risk of Asthma and Allergies
Research shows that growing up on farms can significantly lower the risk of developing asthma and allergies in children by promoting beneficial microbial exposure and immune regulation.
Gut Bacterial Molecule Promotes Kidney Fibrosis in Diabetes
New research reveals that a molecule produced by gut bacteria, corisin, plays a crucial role in promoting kidney fibrosis in diabetic patients. Blocking corisin could offer a novel approach to prevent kidney failure.
Australia's Leading Pharmaceutical Companies Urged to Reduce Carbon Emissions
Australian pharmaceutical companies are being called to action to significantly reduce their carbon emissions and embrace sustainable practices to combat climate change and meet regulatory standards.
Addressing Gaps in Hepatitis C Treatment Among Vulnerable Populations
Recent research highlights disparities in hepatitis C treatment among children and pregnant women, emphasizing the need for targeted strategies to eliminate the virus and improve care for vulnerable populations.



